SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
+12.16%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$453M
AUM Growth
+$453M
(-9.1%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-22.95%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
2
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$55.7M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$47.7M |
| 3 |
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
|
$564K |
Sector Composition
| 1 | Healthcare | 87.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$19.4B
| $163M | 36% | 461,858 | – | – |
|
2
Innoviva
INVA
$1.29B
| $69.1M | 15.25% | 4,535,000 | – | – |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $65.5M | 14.45% | 344,000 | – | – |
|
4
Ironwood Pharmaceuticals
IRWD
$214M
| $62.2M | 13.71% | 3,367,100 | – | – |
|
|
MDCO
5
DELISTED
Medicines Co
MDCO
| $57.5M | 12.68% | 1,922,000 | – | – |
|
|
ICPT
6
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $32.5M | 7.18% | 257,500 -377,800 | -59% | -$47.7M |
|
|
NVLN
7
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $3.03M | 0.67% | 1,025,000 | – | – |
|
|
SHPG
8
DELISTED
Shire pic
SHPG
| $181K | 0.04% | 1,000 -308,000 | -100% | -$55.7M |
|
9
AbbVie
ABBV
$372B
| $94K | 0.02% | 1,000 | – | – |
|
|
SEEL
10
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| – | – | -1,447,906 | Closed | -$564K |
|